DEC 08, 2018 10:51 AM PST

Regenerating Beta Cells to Cure Diabetes

WRITTEN BY: Carmen Leitch

It’s been established that cells in the islet of the pancreas called beta cells produce a critical hormone that controls blood sugar - insulin. However, those cells can get tapped out for a variety of reasons, sometimes because they’re overworked or in other cases because the immune system destroys them. Ultimately the loss of those cells results in a lack of insulin and chronically high blood sugar - diabetes. Researchers have long speculated that getting those cells to regrow would be a way to cure diabetes; but first, they have to figure out how if it's possible. 

Writing in Trends in Endocrinology & Metabolism, scientists from the Diabetes Research Institute at the University of Miami (DRI) have now said that progenitor stem cells do exist in the pancreas. These cells, said the scientists, can regenerate in humans. This article is meant to settle a debate about how to coax those cells to grow.

"We have demonstrated that there are progenitors in the adult pancreas, not only in mice but in humans, which is a very important clarification, and that those cells can potentially be stimulated through pharmacological means to induce regeneration in patients with type 1 diabetes. That is the 'Holy Grail' of what we are trying to achieve here at the DRI," explained Juan Dominguez-Bendala, Ph.D., director of pancreatic stem cell development for translational research. He was the co-author of the report with Ricardo Pastori, Ph.D., director of molecular biology.

Decades ago, researchers suggested that progenitor cells lived in the duct of the adult pancreas. That catalyzed investigations into how to stimulate ductal cells to specialize into other types of cells in the pancreas, including those that make insulin. 

A technique called lineage tracing was used later to trace the development of pancreatic cells. It showed that insulin-producing beta cells are replenished when existing cells divide; they were not coming from the growth of fresh ones.

The DRI researchers think that there were flaws in the model used to reach those conclusions. One major caveat was introduced when mice were used; there are huge differences between mouse and human islets.

"The hypothesis that the pancreas harbors progenitor cells has been discredited for a number of years, but we believe that many of the techniques used to reach that conclusion were flawed. We have found profound differences in the behavior of human cells versus mouse cells in the pancreas, and we think it's important to highlight and emphasize the regeneration processes in human cells," explained Dr. Dominguez-Bendala. "Clearly, our work and the work of others is actually contributing to the notion that we have stem cells in the adult pancreas, and that we can potentially exploit those cells to our benefit for the treatment of type 1 diabetes."

Type 1 diabetes happens after the body’s immune system mistakenly attacks pancreatic beta cells and kills them. Patients have to monitor and inject insulin every day — the only ones that don’t have received successful islet transplants. We don’t have enough of those healthy islets to cure every type 1 diabetic, however. A potential solution is getting patients to regrow their own cells.

"If we could give the patient something that will promote the proliferation and subsequent differentiation of those cells that are already in the pancreas into beta cells while controlling autoimmunity, we could harness the natural ability of the body to heal itself. We think that would open a whole new therapeutic horizon," said Dr. Dominguez-Bendala.

 

Sources: AAAS/Eurekalert! Via DRI, Cell ReportsTrends in Endocrinology & Metabolism

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 24, 2019
Cell & Molecular Biology
JAN 24, 2019
Scientists Use CRISPR Gene Editing in Mice Successfully
Researchers are getting closer to modeling complex diseases that affect multiple genes in an animal....
JAN 28, 2019
Genetics & Genomics
JAN 28, 2019
New CRISPR Enzyme is Ready for Use
The CRISPR gene editing system is usually paired with an enzyme called Cas9. Researchers have now created a new CRISPR enzyme: Cas12b....
FEB 16, 2019
Genetics & Genomics
FEB 16, 2019
Studying the Evolution of the Human Brain
From a genetic perspective, humans are only 1.2% different from chimpanzees and a cousin of theirs, the bonobo....
MAR 10, 2019
Cell & Molecular Biology
MAR 10, 2019
A Skin Bioprinter May Soon Heal Wounds Rapidly
It may sound like science fiction, but researchers are working on developing a printer that can heal wounds....
MAR 13, 2019
Cell & Molecular Biology
MAR 13, 2019
Why do Flowers Bloom in the Spring?
Scientists discover what controls the circadian clock in plants....
MAR 18, 2019
Cell & Molecular Biology
MAR 18, 2019
Antifungal Drug May Bring Relief to CF Patients
Cystic fibrosis affects around 700,000 people worldwide. New research has found a potential treatment for patients that don't respond to current therapies....
Loading Comments...